Cerebrovascular Fibromuscular Dysplasia – A Practical Review

References

• Gornik HL, Persu A, Adlam D, et al. First International Consensus on the diagnosis and management of Fibromuscular dysplasia. Vasc Med. 2019;24(2):164–189. doi:10.1177/1358863X18821816
   PubMed Web of Science ®Google Scholar
• Pappaccogli M, Di monaco S, Warchol-Celinska E, et al. European/International FMD Registry and Initiative (FEIRI) and the working group ‘Hypertension and the Kidney’ of the European Society of Hypertension (ESH). The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI) – clinical phenotypes and their predictors based on a cohort of 1000 patients. Cardiovasc Res. 2021;117(3):950–959. doi:10.1093/cvr/cvaa102
   PubMed Web of Science ®Google Scholar
• Persu A, Dobrowolski P, Gornik HL, et al. Current progress in clinical, molecular and genetic aspects of adult Fibromuscular dysplasia. Cardiovasc Res. 2022;118(1):65–83. doi:10.1093/cvr/cvab086
   PubMed Web of Science ®Google Scholar
• Harriott AM, Zimmerman E, Singhal AB, Jaff MR, Lindsay ME, Rordorf GA. Cerebrovascular Fibromuscular dysplasia: the MGH cohort and literature review. Neurol Clin Pract. 2017;7(3):225–236. doi:10.1212/CPJ.0000000000000339
   PubMedGoogle Scholar
• Touze E, Southerland AM, Boulanger M, et al. Fibromuscular dysplasia and its neurologic manifestations. JAMA Neurol. 2019;76(2):217–226. doi:10.1001/jamaneurol.2018.2848
   PubMed Web of Science ®Google Scholar
• Kythreotou A, Weerakkody RA, Koysombat K, Marzouqa N, Baker DM. A retrospective cohort study of cerebrovascular Fibromuscular dysplasia. Ann Vasc Surg. 2023;92:S0890–5096. doi:10.1016/j.avsg.2022.12.092
   PubMed Web of Science ®Google Scholar
• Olin JW, Froehlich J, Gu X, et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation. 2012;125(25):3182–3190. doi:10.1161/CIRCULATIONAHA.112.091223
   PubMed Web of Science ®Google Scholar
• Plouin PF, Baguet JP, Thony F, et al. ARCADIA investigators. High prevalence of multiple arterial bed lesions in patients with fibromuscular dysplasia: the ARCADIA Registry (assessment of renal and cervical artery dysplasia). Hypertension. 2017;70(3):652–658. doi:10.1161/HYPERTENSIONAHA.117.09539
   PubMed Web of Science ®Google Scholar
• Wells BJ, Modi RD, Gu X, et al. Clinical associations of headaches among patients with Fibromuscular dysplasia: a report from the US Registry for Fibromuscular Dysplasia. Vasc Med. 2020;25(4):348–350. doi:10.1177/1358863X20923740
   PubMed Web of Science ®Google Scholar
• Dicks AB, Gornik HL, Gu X, et al. Association of fibromuscular dysplasia and pulsatile tinnitus: a report of the US Registry for Fibromuscular Dysplasia. J Am Heart Assoc. 2021;10(17):e021962. doi:10.1161/JAHA.121.021962
   PubMed Web of Science ®Google Scholar
• Persu A, Giavarini A, Touze E, et al. European consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens. 2014;32(7):1367–1378. doi:10.1097/HJH.0000000000000213
   PubMed Web of Science ®Google Scholar
• Olin JW, Gornik HL, Bacharach JM, et al. Fibromuscular Dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation. 2014;129(9):1048–1078. doi:10.1161/01.cir.0000442577.96802.8c
   PubMed Web of Science ®Google Scholar
• Sethi SS, Lau JF, Godbold J, Gustavson S, Olin JW. The S curve: a novel morphological finding in the internal carotid artery in patients with fibromuscular dysplasia. Vasc Med. 2014;19(5):356–362. doi:10.1177/1358863X14547122
   PubMed Web of Science ®Google Scholar
• Schievink WI, Bjornsson J. Fibromuscular dysplasia of the internal carotid artery: a clinicopathological study. Clin Neuropathol. 1996;15(1):2–6.
   PubMed Web of Science ®Google Scholar
• Kadian-Dodov D, Goldfinger JZ, Gustavson S, Olin JW. Natural history of cervical artery Fibromuscular dysplasia and associated neurovascular events. Cerebrovasc Dis. 2018;46(1–2):33–39. doi:10.1159/000491437
   PubMed Web of Science ®Google Scholar
• Cloft HJ, Kallmes DF, Kallmes MH, Goldstein JH, Jensen ME, Dion JE. Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia: a reassessment. J Neurosurg. 1998;88(3):436–440. doi:10.3171/jns.1998.88.3.0436
   PubMed Web of Science ®Google Scholar
• Joux J, Boulanger M, Jeannin S, et al. Association between carotid bulb diaphragm and ischemic stroke in young Afro-Caribbean patients: a population-based case control study. Stroke. 2016;47(10):2641–2644. doi:10.1161/STROKEAHA.116.013918
   PubMed Web of Science ®Google Scholar
• Bruno RM, Lascio ND, Guarino D, et al. Abstract p509: identification of radial vascular abnormalities by very high frequency ultrasound in patients with fibromuscular dysplasia: the FUCHSIA study. Hypertension. 2017;70:AP509. doi:10.1161/hyp.70.suppl_1.p509
   Web of Science ®Google Scholar
• Southerland AM, Meschia JF, Worrall BB. Shared associations of non-atherosclerotic, large vessel, cerebrovascular arteriopathies: considering intracranial aneurysms, cervical artery dissection, Moya-Moya disease and fibromuscular dysplasia. Curr Opin Neurol. 2013;26(1):13–28. doi:10.1097/WCO.0b013e32835c607f
   PubMed Web of Science ®Google Scholar
• Perdu J, Boutouyrie P, Bourgain C, et al. Inheritance of arterial lesions in renal fibromuscular dysplasia. J Hum Hypertens. 2007;21(5):393–400. doi:10.1038/sj.jhh.1002156
   PubMed Web of Science ®Google Scholar
• Mettinger KL, Ericson K. Fibromuscular dysplasia and the brain. Observations on angiographic, clinical and genetic characteristics. Stroke. 1982;13(1):46–52. doi:10.1161/01.STR.13.1.46
   PubMed Web of Science ®Google Scholar
• McKenzie GA, Oderich GS, Kawashima A, Misra S. Renal artery fibromuscular dysplasia in 2640 renal donor subjects: a CT angiography analysis. J Vasc Interv Radiol. 2013;24(10):1477–1480. doi:10.1016/j.jvir.2013.06.006
   PubMed Web of Science ®Google Scholar
• Kiando SR, Tucker NR, Castro-Vega LJ, et al. PHACTR1 is a genetic susceptibility locus for fibromuscular dysplasia supporting its complex genetic pattern of inheritance. PLoS Genet. 2016;12(10):e1006367. doi:10.1371/journal.pgen.1006367
   PubMed Web of Science ®Google Scholar
• PHACTR1 phosphatase and actin regulator. Available from: https://www.ncbi.nlm.nih.gov/gene/221692. Accessed March 03, 2023.
   Google Scholar
• Saw J, Yang ML, Trinder M, et al. Chromosome 1q21. 2 and additional loci influence risk of spontaneous coronary artery dissection and myocardial infarction. Nat Commun. 2020;11(1):4432. doi:10.1038/s41467-020-17558-x
   PubMed Web of Science ®Google Scholar
• Adlam D, Olson TM, Combaret N, et al. Association of the PHACTR1/EDN1 genetic locus with spontaneous coronary artery dissection. J Am Coll Cardiol. 2019;73(1):58–66. doi:10.1016/j.jacc.2018.09.085
   PubMed Web of Science ®Google Scholar
• Georges A, Albuisson J, Berrandou T, et al. Rare loss-of-function mutations of PTGIR are enriched in fibromuscular dysplasia. Cardiovasc Res. 2021;117(4):1154–1165. doi:10.1093/cvr/cvaa161
   PubMed Web of Science ®Google Scholar
• Richer J, Hill HL, Wang Y, et al. A novel recurrent COL5A1 genetic variant is associated with a dysplasia-associated arterial disease exhibiting dissections and fibromuscular dysplasia. Arterioscler Thromb Vasc Biol. 2020;40(11):2686–2699. doi:10.1161/ATVBAHA.119.313885
   PubMed Web of Science ®Google Scholar
• Sang CN, Whelton PK, Hamper UM, et al. Etiologic factors in renovascular fibromuscular dysplasia. A case-control study. Hypertension. 1989;14(5):472–479. doi:10.1161/01.HYP.14.5.472
   PubMed Web of Science ®Google Scholar
• Savard S, Azarine A, Jeunemaitre X, Azizi M, Plouin PF, Steichen O. Association of smoking with phenotype at diagnosis and vascular interventions in patients with renal artery fibromuscular dysplasia. Hypertension. 2013;61(6):1227–1232. doi:10.1161/HYPERTENSIONAHA.111.00838
   PubMed Web of Science ®Google Scholar
• O’Connor S, Gornik HL, Froehlich JB, et al. Smoking and adverse outcomes in fibromuscular dysplasia: US Registry Report. J Am Coll Cardiol. 2016;67(14):1750–1751. doi:10.1016/j.jacc.2016.01.058
   PubMed Web of Science ®Google Scholar
• Mackay A, Brown JJ, Cumming AM, Isles C, Lever AF, Robertson JI. Smoking and renal artery stenosis. Br Med J. 1979;2(6193):770. doi:10.1136/bmj.2.6193.770
   PubMedGoogle Scholar
• Kaufman JJ, Hanafee W, Maxwell MH. Upright renal arteriography in the study of renal hypertension. JAMA. 1964;187(13):977–980. doi:10.1001/jama.1964.03060260005001
   PubMed Web of Science ®Google Scholar
• Boutouyrie P, Gimenez-Roqueplo AP, Fine E, et al. Evidence for carotid and radial artery wall subclinical lesions in renal fibromuscular dysplasia. J Hypertens. 2003;21(12):2287–2295. doi:10.1097/00004872-200312000-00017
   PubMed Web of Science ®Google Scholar
• Bruno RM, Marais L, Khettab H, et al. Deep vascular phenotyping in patients with renal multifocal fibromuscular dysplasia. Hypertension. 2019;73(2):371–378. doi:10.1161/HYPERTENSIONAHA.118.12189
   PubMed Web of Science ®Google Scholar
• Weinberg I, Gu X, Giri J, et al. Anti-platelet and antihypertension medication use in patients with fibromuscular dysplasia: results from the United States Registry for Fibromuscular dysplasia. Vasc Med. 2015;20(5):447–453. doi:10.1177/1358863X15584982
   PubMed Web of Science ®Google Scholar
• Nguyen N, Sharma A, West JK, et al. Presentation, clinical features, and results of intervention in upper extremity fibromuscular dysplasia. J Vasc Surg. 2017;66(2):554–563. doi:10.1016/j.jvs.2017.02.049
   PubMed Web of Science ®Google Scholar
• Kadian-Dodov D, Gornik HL, Gu X, et al. Dissection and aneurysm in patients with fibromuscular dysplasia: findings from the U.S. Registry for FMD. J Am Coll Cardiol. 2016;68(2):176–185. doi:10.1016/j.jacc.2016.04.044
   PubMed Web of Science ®Google Scholar
• Brott TG, Halperin JL, Abbara S, et al.; American College of Cardiology Foundation; American Stroke Association; American Association of Neurological Surgeons; American College of Radiology; American Society of Neuroradiology; Congress of Neurological Surgeons; Society of Atherosclerosis Imaging and Prevention; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society of Neuro-interventional Surgery; Society for Vascular Medicine; Society for Vascular Surgery. 2011ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Neurointerventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Circulation. 2011;124(4):489–532. doi:10.1161/CIR.0b013e31820d8d78
   PubMedGoogle Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European society of Cardiology and the European society of hypertension: the task force for the management of arterial hypertension of the European society of Cardiology and the European society of Hypertension. J Hypertens. 2018;36(10):1953–2041.
   PubMed Web of Science ®Google Scholar
• Whelton PK A, Carey RM, Aronow WS, et al. 2017 ACC/ AHA /AAPA /ABC /ACPM /AGS /APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127–e248. doi:10.1016/j.jacc.2017.11.006
   PubMed Web of Science ®Google Scholar
• Dworkin LD, Cooper CJ. Clinical practice. Renal-artery stenosis. N Engl J Med. 2009;361(20):1972–1978. doi:10.1056/NEJMcp0809200
   PubMed Web of Science ®Google Scholar
• Saw J, Humphries K, Aymong E, et al. Spontaneous coronary artery dissection: clinical outcomes and risk of recurrence. J Am Coll Cardiol. 2017;70(9):1148–1158. doi:10.1016/j.jacc.2017.06.053
   PubMed Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46–e110. doi:10.1161/STR.0000000000000158
   PubMed Web of Science ®Google Scholar
• Markus HS, Hayter E, Levi C, et al. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial. Lancet Neurol. 2015;14(4):361–367.
   PubMed Web of Science ®Google Scholar
• Rahme RJ, Aoun SG, McClendon J, El Ahmadieh TY, Bendok BR. Spontaneous cervical and cerebral arterial dissections: diagnosis and management. Neuroimaging Clin N Am. 2013;23(4):661–671. doi:10.1016/j.nic.2013.03.013
   PubMed Web of Science ®Google Scholar
• Etminan N, Rinkel GJ. Unruptured intracranial aneurysms: development, rupture and preventive management. Nat Rev Neurol. 2016;12(12):699–713. doi:10.1038/nrneurol.2016.150
   PubMed Web of Science ®Google Scholar
• Lather HD, Gornik HL, Olin JW, et al. Prevalence of intracranial aneurysm in women with fibromuscular dysplasia: a report from the US Registry for Fibromuscular Dysplasia. JAMA Neurol. 2017;74(9):1081–1087. doi:10.1001/jamaneurol.2017.1333
   PubMed Web of Science ®Google Scholar
• Sandvei MS, Romundstad PR, Müller TB, Vatten L, Vik A. Risk factors for aneurysmal subarachnoid haemorrhage in a prospective population study: the HUNT study in Norway. Stroke. 2009;40(6):1958–1962. doi:10.1161/STROKEAHA.108.539544
   PubMed Web of Science ®Google Scholar
• Mac Grory B, Emmer BJ, Roosendaal SD, et al. Carotid web: an occult mechanism of embolic stroke. J Neurol Neurosurg Psychiatry. 2020;91(12):1283–1289. doi:10.1136/jnnp-2020-323938
   PubMed Web of Science ®Google Scholar
• Patel SD, Otite FO, Topiwala K, et al. Interventional compared with medical management of symptomatic carotid web: a systematic review. J Stroke Cerebrovasc Dis. 2022;31(10):106682. doi:10.1016/j.jstrokecerebrovasdis.2022.106682
   PubMed Web of Science ®Google Scholar
• Haussen DC, Grossberg JA, Koch S, et al. Multi-centre experience with stenting for symptomatic carotid web. Interv Neurol. 2018;7(6):413–418. doi:10.1159/000489710
   PubMed Web of Science ®Google Scholar
• Burch R. Preventive migraine treatment. Continuum. 2021;27(3):613–632. doi:10.1212/CON.0000000000000957
   PubMedGoogle Scholar
• Ailani J. Acute migraine treatment. Continuum. 2021;27(3):597–612. doi:10.1212/CON.0000000000000956
   PubMedGoogle Scholar
• Favoni V, Giani L, Al-Hassany L, et al. CGRP and migraine from cardiovascular point of view: what do we expect from blocking CGRP? J Headache Pain. 2019;20(1):27.
   PubMed Web of Science ®Google Scholar
• Wattiez AS, Sowers LP, Russo AF. Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting. Expert Opin Ther Targets. 2020;24(2):91–100. doi:10.1080/14728222.2020.1724285
   PubMed Web of Science ®Google Scholar
• Smillie SJ, Brain SD. Calcitonin gene-related peptide (CGRP) and its role in hypertension. Neuropeptides. 2011;45(2):93–104. doi:10.1016/j.npep.2010.12.002
   PubMed Web of Science ®Google Scholar
• MaassenVanDenBrink A, Meijer J, Villalon CM, Ferrari MD. Wiping out CGRP: potential cardiovascular risks. Trends Pharmacol Sci. 2016;37(9):779–788. doi:10.1016/j.tips.2016.06.002
   PubMed Web of Science ®Google Scholar
• Robblee J, Harvey LK. Cardiovascular disease and migraine: are the new treatments safe? Curr Pain Headache Rep. 2022;26(8):647–655. doi:10.1007/s11916-022-01064-4
   PubMed Web of Science ®Google Scholar
• Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia. 2015;35(6):478–488. doi:10.1177/0333102414547138
   PubMed Web of Science ®Google Scholar
• Hall GC, Brown MM, Mo J, MacRae KD. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology. 2004;62(4):563–568. doi:10.1212/01.WNL.0000110312.36809.7F
   PubMed Web of Science ®Google Scholar
• Ghanshani S, Chen C, Lin B, Duan L, Shen YA, Lee MS. Risk of acute myocardial infarction, heart failure, and death in migraine patients treated with triptans. Headache. 2020;60(10):2166–2175. doi:10.1111/head.13959
   PubMed Web of Science ®Google Scholar
• Pasquini M, Trystram D, Nokam G, Gobin-Metteil MP, Oppenheim C, Touze E. Fibromuscular dysplasia of cervicocephalic arteries: prevalence of multisite involvement and prognosis. Rev Neurol. 2015;171(8–9):616–623. doi:10.1212/CON.0000000000000956
   PubMedGoogle Scholar
• Shah KP, Peruri A, Kanneganti M, et al. Fibromuscular dysplasia: a comprehensive review on evaluation and management and role for multidisciplinary comprehensive care and patient input model. Semin Vasc Surg. 2021;34(1):89–96. doi:10.1053/j.semvascsurg.2021.02.009
   PubMed Web of Science ®Google Scholar